Skip Navigation

CostCheck™ Quarterly Q2, 2022

CostCheck™ Quarterly Q2, 2022

Bluesight® is sharing data from its CostCheck product on a quarterly basis to show where and how its customers are saving money. CostCheck ingests real-time drug pricing and purchasing data to drive analytics that optimize product selection, GPO compliance, 340B optimization and contract price parity.

CostCheck has saved its customers over 17 million dollars. In fact, in Q2 2022 alone, CostCheck saved its customers over 3 million dollars. Download the latest information about our suite of medication intelligence products by using the button below.

Download the latest information about our suite of medication intelligence products by using the button below.

Want to read the rest?
Case Study

Case Study: Niagara Falls Memorial Medical Center Finds 4% in Annual Drug Spend Savings with CostCheck

The goal was to become less reactive to more proactive when managing pharmacy budgets and…

Learn More

Blog Post

BluesightⓇ Partners with Fagron to Expand the Availability of Pre-Tagged Medication

Learn More

Research

340B Infographic

Hospital pharmacies and their 340B teams are often already overtaxed and have limited time and…

Learn More

Blog Post

The Evolution of 340B and the Challenges it Faces; is Technology the Answer?

Learn More